Regeneron Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
Portfolio Pulse from
Regeneron Pharmaceuticals, Inc. is facing a class action lawsuit with a lead plaintiff deadline set for March 10, 2025. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.
March 03, 2025 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is involved in a class action lawsuit, which could impact its stock price. Investors have until March 10, 2025, to join as lead plaintiffs.
The class action lawsuit against Regeneron Pharmaceuticals could lead to financial liabilities or reputational damage, potentially affecting its stock price negatively in the short term. The deadline for lead plaintiffs is March 10, 2025, which may create uncertainty among investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100